Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000458089 | SCV000549086 | likely benign | Gorlin syndrome | 2025-01-23 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV001022065 | SCV001183757 | likely benign | Hereditary cancer-predisposing syndrome | 2018-08-13 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Laboratory of Molecular Epidemiology of Birth Defects, |
RCV003153625 | SCV003843494 | benign | Ovarian cancer | 2022-01-01 | criteria provided, single submitter | clinical testing |